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Abstract.  Myosin is identified and purified from three 
different established Drosophila melanogaster cell 
lines (Schneider's lines 2 and 3 and Kc).  Purification 
entails lysis in a low salt,  sucrose buffer that contains 
ATP,  chromatography on DEAE-cellulose, precipita- 
tion with actin in the absence of ATP,  gel filtration in 
a discontinuous KI-KCI buffer system, and hydrox- 
ylapatite chromatography.  Yield of pure cytoplasmic 
myosin is 5-10%. 
This protein is identified as myosin by its cross- 
reactivity with two monoclonal antibodies against hu- 
man platelet myosin, the molecular weight of its heavy 
chain,  its two light chains,  its behavior on gel filtra- 
tion,  its ATP-dependent affinity for actin,  its character- 
istic ATPase activity, its molecular morphology as 
demonstrated by platinum  shadowing, and its ability to 
form bipolar filaments. 
The molecular weight of the cytoplasmic myosin's 
light chains and peptide mapping  and immunochemical 
analysis of its heavy chains demonstrate that this myo- 
sin,  purified from Drosophila cell lines,  is distinct 
from Drosophila muscle myosin.  Two-dimensional thin 
layer maps of complete proteolytic digests of iodinated 
muscle and cytoplasmic myosin heavy chains demon- 
strate that,  while the two myosins have some tryptic 
and alpha-chymotryptic peptides in common, most 
peptides migrate with unique mobility. One-dimension- 
al peptide maps of SDS PAGE purified myosin heavy 
chain confirm these structural data.  Polyclonal antise- 
rum raised and reacted against Drosophila myosin iso- 
lated from cell lines cross-reacts only weakly with 
Drosophila muscle myosin isolated from the thoraces 
of adult Drosophila. Polyclonal antiserum raised 
against Drosophila muscle myosin behaves in a 
reciprocal fashion.  Taken together our data suggest 
that the myosin purified from Drosophila cell lines is 
a bona fide cytoplasmic myosin and is very likely the 
product of a different myosin gene than the muscle 
myosin heavy chain gene that has been previously 
identified and characterized. 
M 
YOSIN, a hexameric protein that usually consists of 
two heavy and four light polypeptide chains, is the 
mechanochemical  force transducer that  interacts 
with actin to convert energy from the hydrolysis of ATP into 
force for muscular contraction (reviewed in Harrington and 
Rodgers,  1984). In higher eukaryotes,  cytoplasmic isoforms 
of myosin can be identified and presumably generate such di- 
verse cellular motilities  as platelet-mediated  clot retraction, 
intracellular  vesicle movement, cytoplasmic  streaming,  cell 
locomotion, and cytokinesis (Pollard,  1981). Indeed, a func- 
tional  role for cytoplasmic  myosin  in cytokinesis  has been 
demonstrated best in antibody injection  studies:  anti-cyto- 
plasmic myosin  specifically  inhibits  actin-activated  myosin 
ATPase activity in vitro and, when microinjected into living 
cells,  inhibits  the  function  of the  contractile  ring  during 
cleavage in a specific and dose-dependent fashion (Mabuchi 
and Okuno,  1977; Kiehart  et al.,  1982). 
In avian and mammalian  species, distinct isoforms of both 
myosin heavy and light chains are responsible for contractil- 
ity in skeletal,  cardiac,  smooth muscle, and nonmuscle tis- 
sues (reviewed in Nadal-Ginard  et al.,  1982; Whalen et al., 
1982; and Buckingham  and Minty,  1983). Further diversity 
is common even within a particular tissue: fast and slow iso- 
forms of skeletal muscle, distinct isoforms of atrial and ven- 
tricular  cardiac muscle (reviewed  in  Nadal-Ginard  et al., 
1982; Whalen  et al.,  1982; and  Buckingham  and  Minty, 
1983),  and distinct  isoforms  of cytoplasmic  myosin (Bur- 
ridge and Bray, 1975; Wong et al., 1985) have been identified. 
While the origin of this diversity is not uniformly clear, some 
of it is specified at the DNA level (Nadal-Ginard  et al., 1982; 
Buckingham and Minty, 1983; Robbins et al., 1986). In avian 
and mammalian  species, the myosin heavy chain gene family 
apparently  consists of ~10 distinct but closely related mem- 
bers. In avian species there are as many as 20 more distantly 
related  forms.  The  heterogeneity  in  myosin  heavy  chain 
genes may reflect differences  in sequence that alter regula- 
tion of the gene's expression, allowing coordinate expression 
with different sets of genes in different tissues or cell types 
at various times during development.  Alternately, genes that 
differ in the sequence of their protein coding regions may re- 
sult in appropriate  expression of specific  isoforms that are 
custom-tailored  for their particular  mechanochemical appli- 
cation. 
In contrast to the mammalian  and avian systems described 
above,  only a  single  myosin  heavy chain  gene  has  been 
identified  in Drosophila (Bernstein  et al.,  1983; Rozek and 
©  The Rockefeller University Press, 0021-9525/86/10/1517/09  $1.00 
The Journal of Cell Biology, Volume 103, October  1986 1517-1525  1517 Davidson,  1983). This suggests three interesting possibili- 
ties: That no diversity in myosin isoforms is necessary in 
Drosophila, that necessary diversity can be accommodated 
by posttranscriptional or posttranslational modifications of 
the products of  a single myosin gene, or that additional, more 
distantly related, and therefore non-cross-hybridizing myo- 
sin heavy chain genes exist. Indeed, alternate splicing of the 
primary transcripts of both myosin heavy and light chain 
genes suggest that posttranscriptional modifications are re- 
sponsible for at least some, albeit minor diversity in myosin 
heavy  and  light chain  isoforms  at  the  polypeptide  level 
(Bernstein et al., 1986; Rozek and Davidson, 1986; Falken- 
thai et al.,  1985). 
Here we purify a protein from Drosophila cell lines, iden- 
tify it  as  myosin by  five  structural  and three  functional 
criteria, and establish on the polypeptide level that its heavy 
chains are extensively different from muscle myosin heavy 
chain isoforms. The substantial differences between muscle 
and cytoplasmic isoforms of Drosophila myosin heavy chain 
support the existence of a distinct myosin gene responsible 
for encoding this cytoplasmic polypeptide. 
Preliminary accounts of this work were presented at meet- 
ings of the American Society for Cell Biology and the Bio- 
physical Society (Kiehart and Feghali, 1985, 1986). 
Materials and Methods 
Cell Culture, Harvest, and Homogenization 
Drosophila Kc and Schneider's 2 and 3 cells are distinct, established cell 
lines that are derived from embryonic tissue explants and do not display 
characteristics of myogenic cell lines (Schneider and Blumenthal,  1978). 
They were grown by standard methods in spinner culture (Schneider and 
Blumenthal,  1978). Approximately 15-30 g (wet weight) of cells grown to 
a  density of 0.5-2  x  107 cells/ml were harvested by centrifugation and 
washed three times by gentle sedimentation and resuspension in ice-cold 
phosphate-buffered saline (PBS; 150 mM NaCI,  10 mM NaPO4,  pH 7.2). 
All subsequent steps were performed at 0-4°C unless otherwise specified. 
Washed cells were resuspended in  10 vol of PBS, incubated in diisopro- 
pylfluorophosphate (5.7 mM final concentration) for 5 rain, washed in fresh 
PBS, then resuspended in 4-6 vol of ice-cold homogenization buffer (0.34 
M sucrose, 20 mM imidazole-C1, pH 7.0, 5 mM EGTA, 5 mM ATE 5 mM 
dithiothreitol [DTT], ~ 5 mM phenylmethylsulfonyl fluoride, 3 mM NAN,, 
22 ~tM Pepstatin A, 0.25 mg/ml soybean trypsin inhibitor). Cells were lysed 
by sonication with a  Branson sonifier set at maximum for a microtip (40 
W). Cell homogenates were fractionated by centrifugation at 43,0(10 rpm in 
a Sorvall T647.5  rotor (137,600 g~v). 
Purification of  Myosin  from the 
High Speed Supernatant 
The supernatant was chromatographed on DEAE-cellulose (DE-52, What- 
man Inc., Clifton, NJ; prepared as described by Pollard,  1982) that was 
equilibrated with homogenization buffer in the absence of proteolytic inhibi- 
tors. Approximately 100 ml of high speed supernatant was applied to a 2.5 
×  35-cm column. The column was washed with 3-5 vol of homogenization 
buffer, then eluted with 0.8-1  liter of a  linear, 0-0.5  M  KCI  gradient in 
homogenization buffer.  Fractions that contained myosin were pooled. 
Subsequent purification relied on the high affinity of myosin for actin in 
the absence of ATP. Endogenous Drosophila actin in the high speed super- 
natant or in selected fractions from DEAE-chromatography was polymer- 
ized by warming the sample to 25°C, adjusting the KCI concentration to 
50-110  mM (fractions from DEAE were already ",,110 mM in KCI), then 
adding MgCI2 to a final concentration of 2 raM. To maximize recovery of 
myosin in subsequent steps, additional actin was required. Chicken F-actin 
1. Abbreviation used in this paper:  DTT,  dithiothreitol. 
(in 50 mM KCI, 2 ram MgC12, 2 mM Tris-Cl, pH 8.0, 0.75 mM NAN3, 0.5 
mM DTT, 0.2 mM ATP, 0.2 mM CaC12), purified by established protocols 
(Spudich and Watt,  1971; Pardee and Spudich, 1982),  was added to a final 
concentration of 0.25 mg/ml. Exogenous chicken actin did not contain any 
contaminating polypeptides that co-migrate with the 205-kD band as shown 
by SDS PAGE of heavily overloaded samples (data not shown). In addition, 
polyclonal antibodies made against the purified Drosophila cytoplasmic my- 
osin (see below) did not cross-react with purified chicken skeletal muscle 
myosin on Western blots (data not shown). 
ATP was removed from the mixture of pooled DEAE fractions and exog- 
enous actin after adding glucose (50 mM) and hexokinase (1 U/ml). After 
incubation for 30 rain at 25°C and then for 8-12 h at 0°C, the preparation 
was layered over a 30%  sucrose cushion containing 50 mM KCI, 2 mM 
MgCI2, and I(3 mM imidazole-Cl, pH Z0, and filamentous actin. Any actin 
binding proteins were precipitated by centrifugation at 30,0(0)O3,000  rpm 
in a  Sorvall T1270 rotor (61,300-126,000  g~) for 3 h. Without exogenous 
actin, more than half of the 205-kD polypeptide remained in the supernatant 
(even when the high speed supernatant of cell homogenate was not subjected 
to DEAE chromatography first; Fig. 1 B). With added chicken actin, nearly 
all of the 205-kD polypeptide that otherwise remained in the supernatant 
was sedimented (Fig.  1 C). 
The actomyosin pellet was dissolved in 4.3 ml of KI buffer (0.72 M KI, 
20 mM imidazole-Cl, pH 7.0, 1 mM EGTA, 5 mM DI'T, 5 mM ATP, 3 mM 
NAN3, 10% glycerol), homogenized with a tight-fitting glass pestle Doance, 
then clarified by centrifugation for 30 min at 30,000 rpm in a Sorvall T1270 
(63,400  g~v). The clarified supernatant was gel filtered on a Al5-m (Bio- 
Rad Laboratories, Richmond, CA) column (1.5 x  85 cm) equilibrated with 
KC1 buffer (0.6 M KCI, 10 mM imidazole-Cl, pH 7.0, 1 mM DTT,  1 mM 
EGTA,  3 mM NAN3, 10% glycerol) that was loaded with 12-19 ml of KI 
buffer just before addition of the protein sample. 
Further purification of myosin was achieved by repetition of the actin 
affinity and gel filtration steps and/or by chromatography on hydroxylapatite 
(Bio-Rad Laboratories) equilibrated with 0.5 M KCI, 50 mM imidazole-Cl, 
pH 7.0, 1 mM EGTA, 0.5 mM DTT,  3 mM NAN3, 10% glycerol. Pooled 
fractions from gel filtration were added to the hydroxylapatite in batch (12- 
20 ml/ml bed) and tumbled slowly for '~12 h. The hydroxylapatite with ab- 
sorbed protein was poured into a small column and washed with 5-10 vol 
of equilibration buffer.  Absorbed proteins were eluted with a linear 0-300 
mM KPO4 gradient in equilibration buffer. 
Drosophila Thoracic Muscle Myosin 
Myofibrils from Drosophila thoraces were isolated as detailed by Mogami 
et al. (1982), then dissolved in K/buffer (see above). Subsequent purifica- 
tion of Drosophila muscle myosin was by gel filtration on an agarose A11-m 
column and by hydroxylapatite chromatography as described for the myosin 
purified from Drosophila cell lines. 
SDS PAGE 
PAGE was performed using standard methods (Laemmli, 1971). To prepare 
samples that contained low concentrations of protein for SDS PAGE, ali- 
quots were mixed with exogenous tRNA (from E. coli; Boehringer Mann- 
heim Biocbemicals, Indianapolis, IN), precipitated with 10% TCA as de- 
scribed by Cabib and Polacheck (1984),  then resuspended in SDS sample 
buffer (Laemmli, 1971) with bromophenol blue as an indicator dye. The pH 
was adjusted to near neutrality by the vapor phase addition of NH4OH un- 
til the indicator turned blue. Polyacrylamide gels were stained with Coo- 
massie Brilliant Blue as described elsewhere (Fairbanks et al.,  1971). 
Western Blotting 
Polypeptides were electmphoretically blotted from 5 % polyacrylamide gels 
by a modification of the procedure devised by Towbin etal. (1979; Kiehart 
et al. 1984a; Kiehart et al. 1986). Nitrocellulose blots were incubated briefly 
in STTMB (1f0 mM NaCl, 10 mM Tris-Cl, pH 7.7, 0.1% Triton X-100, 0.1% 
bovine serum albumin, 0.01% thimerosal) or Blotto (110 mM NaC1,  10 mM 
NaPO4,  pH  7.4,  5%  non-fat dry  milk,  0.05%  antifoam A,  and 0.01% 
thimerosal; Johnson and Elder,  1983), then overlaid with antibody in the 
same blocking buffer.  Localization of antibody that bound to the blots was 
accomplished with t2~l-labeled second antibody (Kiehart et al.,  1984a) or 
with peroxidase-labeled second antibody (HyClone Laboratories, Hogan, 
UT) diluted in STTMB or Blotto by 500-2,000-fold, followed by autoradi- 
ography or development for peroxidase reaction product with 4-chloro-1- 
napthol and hydrogen peroxide as substrates (Hawkes et al.,  1982). 
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Cells in Culture 
The concentration of myosin in Drosophila Schneider's 3  cells was esti- 
mated with an antibody binding assay similar to the one used by Kiehart 
and Pollard (1984) to estimate the concentration of myosin-II in Acantha- 
moeba extracts. Dilutions of hydroxytapatite-purified Drosophila cell myo- 
sin were used as standards, a  1,000-fold  dilution of anti-Drosophila cyto- 
plasmic myosin was used to probe a blot that contained both standards and 
whole cell samples, and peroxidase-labeled second antibody was used to es- 
timate first antibody binding. 
Analytical Gel Filtration 
The Stokes radius of Drosophila cytoplasmic myosin was calculated from 
partition coefficients obtained by gel filtration of 0.5-mi samples containing 
80 Ixg/mi myosin on a 1.5 × 85-cm agarose Al5-m column equilibrated with 
KCI buffer by the method of Ackers (1967) as described by Pollard et al. 
(1978). 
Two-dimensional Peptide Maps 
Purified myosins were resolved on SDS PAGE, heavy chains were excised 
from the gel, iodinated, cleaved by trypsin (13 lxg/ml) or alpha-chymotryp- 
sin (200  gg/mi) at 37°C for 8-12  h, then mapped on cellulose thin layer 
plates as detailed by Elder et al. (1977). In each experiment, duplicate gel 
slices for each myosin were processed and revealed precise reproducibility. 
Tryptic maps were performed on three different preparations of cytoplasmic 
myosin and on two preparations of muscle myosin. Alpha-chymotryptic 
maps were performed on two samples each of Drosophila cytoplasmic and 
muscle myosin. In all cases, reproducibility between identically treated 
samples was excellent. To compare reliably the mobility of peptides from 
the two Drosophila myosin heavy chain isoforms, two plates were each spot- 
ted with peptides from either the cytoplasmic or the muscle isoforms, and 
a third composite plate was spotted with equal amounts of both. The pres- 
ence of weak spots was verified by inspection of longer autoradiographic 
exposures and the resolution of closely spaced, strong spots was evaluated 
on shorter exposures. All 47 of the prominent cytoplasmic peptides and all 
43 of the prominent muscle peptides were identified on the composite map. 
Thus  the cytoplasmic and muscle isoform peptides could be compared 
directly, with confidence, despite subtle differences in peptide migration 
from one thin-layer plate to the next. To more quantitatively analyze the data 
each peptide on the cytoplasmic and the muscle myosin map was assigned 
a number and was located on the combined map. Peptides that overlapped 
were considered identical. This is clearly a simplification that tends to over- 
estimate the degree to which the myosins are homologous. 
Platinum Shadowing 
Samples of Drosophila myosins in KCI  column buffer were mixed with 
glycerol to a final concentration of 70% or were dialyzed into a mixture of 
70%  glycerol and  30%  0.6  M  ammonium formate, pH  7.5  and  rotary 
shadowed with platinum as described previously (Kiehart et al.,  1984b; 
Tyler and Branton, 1980). Electron micrographs were taken on a Philips 301 
at magnifications of 25,000. 
ATPase Activity 
ATP hydrolysis by K+-EDTA  -, Ca  ++-, Mg  ++-, and actin-activated Mg  ++- 
ATPases were measured by 32p-gamma-ATP as described previously (Kie- 
hart and Pollard,  1984). 
Actin-Myosin Binding Assay 
Actin (5.3  gM in 2 mM Tris-C1,  pH 8.0, 0.75 mM NaNa, 0.5  mM DTT, 
0.2 mM ATE 0.2 mM CaCI:) was polymerized by the addition of salts (0.6 
M KC1, 20 mM imidazole-Cl, pH 7.0, 4 mM MgC12, 3 mM NAN3, 0.1 mM 
DTT) and incubation at 37°C for 30 min. Parallel samples containing actin 
alone were treated identically. All concentrations shown are for the final 
concentration in the assay. Phalloidin (10 ttM) and glucose (50 mM) were 
added, then samples were either supplemented with 2 mM ATP or depleted 
of ATP by the addition of hexokinase (12 U/ml) and incubated for 5 min 
at 37°C.  Each preparation was chilled to 0*C, mixed with myosin (42 nM, 
assuming a molecular mass of 480 kD), allowed to incubate for 10 min at 
0°C, then layered onto a sucrose cushion (30% sucrose, 0.6 M KCI, 20 mM 
imidazole-C1, 4 mM MgC12, 3 mM NaNa, 0.1 mM DTT) with or without 
2 mM ATP and sedimented for 40 min at 24 psi in a Beckman alrfuge (Beck- 
man Instnmaents, Inc., Palo Alto, CA). The polypeptide composition of the 
supernatants and pellets was analyzed by SDS PAGE. 
Polyclonal Antibodies against Drosophila Myosins 
Polyclonal antibodies were prepared in rabbits by popliteal lymph node in- 
jection (Sigel et al.,  1983) of 3-10 ttg of purified Drosophila cytoplasmic 
or muscle myosin in 0.2 ml of 400 mM NaCI, 5 mM imidazole-Cl, pH 7.0 
mixed with an equal volume of Freund's complete adjuvant. After 1 mo rab- 
bits were boosted with 10-20 gg of purified protein in the same solution 
mixed with Freund's incomplete adjuvant by injection into several sites in- 
tradermally. The antiserum raised against Drosophila cytoplasmic myosin 
reacts with a  single, 205-kD polypeptide on immunoblots of both whole 
Schneider's 3 cell homogenates and of purified myosin from Drosophila cell 
lines (see Results). Preimmune serum showed no reaction against either 
fraction. 
Other Proteins 
Two monoclonal antibodies (PM 1 and PM 4) against human platelet myosin 
were prepared in collaboration with Drs. Albert Wong and Thomas D. Pol- 
lard. They react specifically with myosin from a variety of sources (manu- 
script in preparation; and Wong et al.,  1985).  Chicken myosin and actin 
were purified from chicken muscle and muscle acetone powder by standard 
methods (Kielly and Harrington, 1960; Spudich and Watt,  1971; Pardee and 
Spudich, 1982). 
Protein Concentration 
Protein concentration was estimated with an Amido black dye binding assay 
as described by Nakamura and co-workers (1985),  with chicken skeletal 
muscle myosin as a standard. 
Reagents 
All salts and pH buffers were reagem grade and deionized water (Millipore 
Corp., Bedford, MA) was used throughout these experiments. Suppliers of 
chromatographic resins are given in the text. ATE diisopropylfluorophos- 
phate, EGTA, hexokinase, phenylmethylsulfonyl fluoride, pepstatin A, and 
soybean trypsin inhibitor were from Sigma Chemical Co., St. Louis, MO, 
and fliT was from Sigma Chemical Co.  or Boehringer Mannheim Bio- 
chemicals. SDS was from Bethesda Research Laboratories (Gaithersburg, 
MD) and other reagents for SDS PAGE were from Bio-Rad. 
Results 
Identification, Purification, and Partial 
Characterization of Myosin from Drosophila Cells 
in Culture 
Identification of Myosin in Drosophila Cell Lines. A 205- 
kD  polypeptide  in  three  Drosophila cell  lines,  Kc  and 
Schneider's 2 and 3, was tentatively  identified as myosin by 
establishing  its  cross-reactivity  with two monoclonal anti- 
bodies  directed  against  human  cytoplasmic  myosin  heavy 
chain (Fig.  1). SDS PAGE and Western  blots overlaid with 
these antibodies were used to follow the distribution of the 
205-kD polypeptide during cell fractionation and subsequent 
purification from Schneider's 3  cells.  The majority of the 
205-kD  polypeptide was extracted  into the high speed su- 
pernatant  of cell  homogenate  as  revealed  by  monoclonal 
anti-platelet myosin overlay of Western blots of pellet and su- 
pernatant fractions (Fig.  1). Further extraction of the pellet 
with  10 vol  of homogenization  buffer  supplemented  with 
0.5 M KCI, 40 mM sodium pyrophosphate,  or 1% Triton-X- 
100 did not significantly reduce the amount of 205-kD poly- 
peptide in the high speed pellet (data not shown). 
Purification of Myosin from Droso ahila Cell Lines. Be- 
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tibody against human cytoplasmic myosin and reveals the distri- 
bution  of 205-kD  heavy chain  in  fractions  obtained  during  the 
purification of Drosophila cytoplasmic myosin. Western blots were 
overlaid with PM-4, a monoclonal anti-human platelet myosin anti- 
body. Antibody binding was localized with peroxidase-labeled sec- 
ond antibody. The amount of each fraction that was loaded is indi- 
cated in parentheses and is expressed in thousandths of a percent 
of the total protein (or volume) present in the fraction. Comparison 
of  the relative intensity of  peroxidase label at 205 kD in the superna- 
tant and pellet fractions in B and C reveal that most of the 205-kD 
polypeptide  is not recovered in the actomyosin pellet  unless ex- 
ogenous actin is included.  Chicken  skeletal muscle myosin, also 
stained by this antibody, is in the lane labeled CM. Samples were 
obtained from four steps: (A) The homogenate, including the whole 
cell homogenate (Wh), the high speed supernatant of cell homoge- 
hate (S), and the high speed, cell debris pellet (P). (B) The endoge- 
nous actin pelleting steps (Endo. Actin; steps not usually included 
during  standard  purification  but  shown  here  to  document  the 
efficacy of adding exogenous actin), including the supernatant (S) 
that followed centrifugation of the endogenous actin-myosin  com- 
plex and the actomyosin pellet (P). (C) The exogenous actin pellet- 
ing steps (Exog. Actin) including the supernatant (S) following cen- 
trifugation of  the supernatant from B after the addition of exogenous 
chicken skeletal muscle actin and the exogenous actin-myosin com- 
plex pellet (P). (D) The KI-solubilized actomyosin pellet after cen- 
trifugation  that  resulted  in  a  clarified  supernatant  (S)  and  the 
KI-insoluble pellet (P). 
havior  of the  205-kD  polypeptide during  purification,  in 
part, helps to identify the polypeptide as a bona fide myosin. 
The  high  speed  supernatant  was  chromatographed  on 
DEAE cellulose to remove contaminating nucleic acids and 
enrich  for the  205-1d)  polypeptide.  Fractions  eluting  be- 
tween 0.13 and 0.2 M KC1 contained an immunoreactive 205- 
kD  polypeptide  and  a  prominent  205-ki)  polypeptide  on 
Coomassie Blue-stained gels. These fractions were pooled. 
Like other myosins, more of the protein that contains 205- 
kD polypeptide binds to F-actin in the absence of ATP than 
in  its presence as shown in  co-sedimentation experiments 
(Fig. 2). To take advantage of this property during purifica- 
tion  of  the  Drosophila  205-kD  polypeptide,  exogenous 
F-actin (see  Materials  and Methods)  was added to pooled 
fractions  from  DEAE,  ATP  was  removed by  addition  of 
hexokinase  and  glucose,  then the  actin  and  actin-binding 
proteins  were  precipitated  by  high  speed  centrifugation 
Figure 2. ATP inhibits the binding of 205-kD polypeptide to actin 
filaments. Coomassie Blue-stained SDS PAGE was used to analyze 
the polypeptide composition of supernatants from an actin-myosin 
co-pelleting experiment. Myosin quantitatively remained in the su- 
pernatant  in the absence or presence of 2 mM ATP (M and MT, 
respectively). In contrast,  sedimentation of myosin in the presence 
of actin is profoundly inhibited by the presence of ATE Nearly all 
of  the myosin co-sediments with actin in the absence of ATP (AM), 
but most remains in the supernatant in the presence of 2 mM ATP 
(AMT). The 58-kD band in lanes M and AM is hexokinase, used 
to deplete the samples of ATE SDS PAGE of the pellets confirms 
these results (data not shown). 
through a 30 % sucrose cushion.  Pellets were dissociated in 
potassium iodide solution and fractionated by gel filtration 
(Fig.  3). 
Hydroxylapatite chromatography of fractions pooled from 
the gel filtration column allowed further purification of myo- 
sin,  which eluted  as a  peak at 210  mM KPO4  (Fig.  3  b). 
SDS PAGE of peak fractions revealed at least two light chains 
migrating at  16 and  18 kD. 
Typically  300-500  I~g of hydroxylapatite-purified myo- 
sin was obtained from 20-25 g  (wet weight) of Drosophila 
Schneider's 3  cells.  The concentration of myosin in whole 
cells was estimated by comparing antibody binding on West- 
ern blots of whole cells and of purified cellular myosin (Fig. 
4).  The polyclonal, rabbit antibody that was used for these 
experiments was raised against purified myosin from Dro- 
sophila cells and is specific for myosin as demonstrated by 
antibody overlay of nitrocellulose blots of SDS  PAGE re- 
solved purified myosin or of whole cell sample (Fig. 4). Gel 
lanes that had an equivalent of 53 nl of whole cells contained 
~10-15 ng of myosin. Thus, the concentration of myosin in 
these ceils is '~0.5 ~tM, and the yield of myosin in the most 
highly purified fractions is 5-10%. 
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coelutes with 205-kD heavy chain when cytoplasmic myosin is gel filtered on agarose A15-m. Activity is plotted with respect to the axis 
shown on the left and corresponds to uniform specific activity of rv550 nmol/mg.min across the peak. Lanes include molecular weight 
standards (Std, with molecular weights as in B), chicken myosin (My), numbered fractions from agarose A15-m gel filtration column (10-40, 
after a second cycle of purification by actin affinity and gel filtration; see Materials and Methods), and red blood cell ghosts (rbc). (B) 
SDS PAGE  of •7.5  ~g of Drosophila cytoplasmic myosin purified by hydroxylapatite chromatography reveals two light chains migrating 
at 16 and 18 kD. 
Partial  Characterization  of Myosin  from  Drosophila 
Cell  Lines.  The  205-kD  polypeptide  and  the  K+-EDTA 
ATPase activity, a functional signature of myosin, coeluted 
precisely on gel filtration: specific activity was essentially 
constant across the peak (•550  nmol Pi/mg.min; Fig. 3 a). 
Further analysis of the ATPase activities of the fractions that 
contained 205-kD polypeptide showed other activities indic- 
ative of myosin. They had comparable activities in 10 mM 
CaCl2,  0.5 M  KC1, or 0.05 M KC1 and little activity in the 
presence of 5 mM MgC12 in 0.01 M  KCI. Gel filtration re- 
vealed that the 205-kD polypeptide elutes with a partition 
coefficient (Kd) of 0.136, which corresponds to a Stokes ra- 
dius of 17 rim. 
Electron microscopy of rotary-shadowed specimens dried 
from glycerol (Fig. 5) revealed that the predominant molecu- 
lar species in the fractions that contain 205-kD polypeptide 
and K+-EDTA ATPas¢ activity was myosin: The two-headed 
molecules have a long tail (132 nm average) and aggregate in 
180 mM ammonium formate to form bipolar filaments that 
have a bare zone averaging 204 nm (:t:  19 rim, n  =  5) with 
projecting heads at each end (14.9  +  3 heads per end). This 
suggests that each filament consists of 16 myosin molecules 
with antiparallel tails that overlap >60 nm or almost half of 
their length. 
Drosophila  Cytoplasmic and Muscle Myosin Isoforms 
Can Be Distinguished Structurally 
and ImmunochemicaUy 
In addition to differences between the molecular weight of 
this myosin's and Drosophila muscle myosin's light chains, 
structural and immunological analyses of its heavy chains 
suggest that this myosin is a true cytoplasmic isoform of  myo- 
sin,  distinct from the muscle isoforms previously isolated 
from Drosophila thorax. 
Two-dimensional  Peptide  Maps  Reveal  Significant 
Differences  between  Drosophila  Cytoplasmic  and  Tho- 
racic Muscle Myosin Heavy Chains.  The structural rela- 
tionship between these two Drosophila myosins was revealed 
in two-dimensional peptide mapping experiments (Fig. 6). 
Even cursory inspection of the  maps  revealed significant 
differences in  the  structure of these two related proteins: 
most of the cytoplasmic and  muscle myosin peptides  ap- 
peared to migrate with unique mobility as determined by 
comparing the position, shape, and intensity of the various 
spots (several uniquely migrating spots are highlighted with 
arrows in  Fig.  6).  When the maps  were compared semi- 
quantitatively (see Materials and Methods), approximately 
half of the tryptic peptides from Drosophila cytoplasmic (23 
of 47) and muscle (22 of 43) myosins were observed to mi- 
Kiehart and Feghali Cytoplasmic Myosin  1521 Figure  4. The specificity  of anti-Drosophila  cytoplasmic  myosin  an- 
tibody and the concentration of myosin in Drosophila cells in cul- 
ture. Anti-Drosophila cytoplasmic myosin was used to overlay a 
Western blot of a dilution series of purified cytoplasmic  myosin  and 
whole cell sample. Antibody was localized with peroxidase-labeled 
goat anti-rabbit antibody. The dilution series of purified Drosoph- 
ila cell myosin  (A) verifies  that the antibody reacts with myosin  and 
provides a standard for estimating the concentration of myosin in 
the dilution series of whole cell sample (B). The amount (in nano- 
grams) of cellular myosin standard is given at the top of each lane. 
The relative volume of whole cell sample loaded is given  in nano- 
liters, and reflects  the extent  to which cells were diluted during sam- 
ple preparation. Each lane of both sample and standard was actually 
loaded with 20 BI of sample. The lane containing 53 nl of sample 
contained 10-15 ng of total protein. 
grate with unique mobility on the two-dimensional maps. 
The remaining peptides overlapped on the composite map. 
Some of these overlapping peptides probably precisely co- 
migrated with one another while others were close to one an- 
other but likely to be distinct. Thus, the resolution of the 
semi-quantitative analysis used was insufficient to document 
the relationship between these polypeptides unambiguously 
and tended to overestimate the degree to which the myosins 
are homologous. 
Overall, the data suggest that, while the two types of myo- 
sin isolated from Drosophila share some homology, signifi- 
cant differences distinguish Drosophila cytoplasmic from 
muscle myosin. Two-dimensional maps of alpha-chymotryp- 
tic peptides of the two Drosophila myosin isoforms and one- 
dimensional  maps  of peptides  generated by  V8  protease 
verify the significant differences in the primary sequences of 
the two polypeptides (data not shown). 
Drosophila  Cytoplasmic  and  Muscle  Myosin  Heavy 
Chains  Can  Be  Distinguished  lmmunoiogicaUy. Poly- 
clonal  antisera  raised  against  either  purified Drosophila 
cytoplasmic myosin or purified Drosophila muscle myosin 
were used to overlay Western blots of Drosophila cytoplas- 
mic and muscle myosins (Fig. 7). These experiments show 
that the two myosin heavy chain isoforms are significantly 
different immunologically. 
Anti-cytoplasmic myosin antibodies distinguished easily 
between the cytoplasmic and muscle isoforms of Drosophila 
myosin heavy chain (Fig. 7). At a 200-fold dilution of anti- 
cytoplasmic myosin, 1 ng of the cytoplasmic myosin isoform 
was detectable. 100 ng of the muscle myosin isoform was re- 
quired to  produce  a  peroxidase  reaction product of only 
slightly greater intensity. At a 2,000-fold dilution of anti- 
cytoplasmic myosin antiserum, reaction products with 10 ng 
of cytoplasmic myosin and 1,000 ng of muscle myosin were 
comparable. Thus the anti-cytoplasmic myosin bound selec- 
tively to cytoplasmic myosin by approximately two orders of 
magnitude. 
The immunological differences between the cytoplasmic 
and muscle isoforms of Drosophila myosin were more strik- 
ing when the Western blots were probed with the anti-mus- 
cle myosin antiserum. While as little as 1 ng of muscle myo- 
sin was detected by 200-fold dilutions of the anti-muscle 
antiserum, 1,000 ng of cytoplasmic antigen was necessary to 
produce a detectable reaction product. At anti-muscle myo- 
sin dilutions of 2,000-fold the reaction product with 1 ng of 
muscle  myosin appeared  approximately equivalent to  the 
reaction product observed with 1,000 ng of cytoplasmic myo- 
sin. Thus the anti-muscle antiserum was even more selective 
than the anti-cytoplasmic antiserum. 
The immunological differences between these isoforms of 
Drosophila myosin have recently been confirmed with an- 
tisera from two mice immunized with Drosophila muscle 
myosin and two mice immunize.d with Drosophila cytoplas- 
mic myosin. Like the rabbit polyclonal antisera described 
above, each of the four antisera displays marked specificity 
for the isoform against which it was made (Lutz, D. A., and 
D.  P.  Kiehart, unpublished observations). 
Discussion 
Five structural criteria, i.e., cross-reaction with monoclonal 
antibodies directed against human platelet myosin, molecu- 
lar weight of myosin heavy chains, existence of two heterol- 
ogous  light chains,  behavior  on  gel  filtration,  molecular 
architecture as revealed by electron microscopy of platinum- 
shadowed  specimens,  and  three  functional  criteria,  i.e., 
ATP-dependent association with actin, high K+-EDTA, and 
Ca++-ATPase activities,  and  ability  to  form bipolar  fila- 
ments, demonstrate that this protein, purified from Drosoph- 
ila cells in culture, is a bona fide myosin. 
Electron  microscopy  of platinum-shadowed  specimens 
and gel filtration of native cytoplasmic myosin demonstrate 
that this myosin is similar in size and shape to other myosins 
and as a consequence likely consists of two heavy chains and 
four light chains. By SDS PAGE, the molecular mass of the 
Drosophila cytoplasmic myosin heavy chains is 205 kD. Two 
bands, migrating on SDS PAGE at 16 and 18 kD, co-purify 
with the 205-kD  heavy chain and are likely myosin light 
chains. The molecular mass of  the light chains of Drosophila 
muscle myosin are 34 or 31 kD (LC 1), 30 kD (LC 2), and 
20 or  18 kD (LC 3),  respectively (Takano-Ohmuro et al., 
1983; Toffenetti, J., personal communication). Thus at least 
one of these light chains is probably unique to the cytoplas- 
mic myosin isoform. 
The Journal of Cell Biology, Volume 103, 1986  1522 Figure 5. Drosophila cytoplasmic myosin has a long tail,  two heads (open arrows), and assembles  into bipolar filaments  (solid arrows) 
with a bare zone. Specimens of Drosophila cytoplasmic myosins purified  by two cycles of precipitation  with actin and gel filtration  were 
rotary platinum shadowed  and photographed at 25,000x.  Bar,  100 nm. 
In preliminary experiments,  actin activation of the Mg  ++- 
ATPase activity of Drosophila cytoplasmic myosin has not 
been demonstrated.  This  is not surprising  and is probably 
due to our failure to identify appropriate conditions for activ- 
ity, which may require variation in solution conditions or in 
the state of phosphorylation of the heavy or light chains. 
In addition to differences between the molecular weight of 
Drosophila cytoplasmic and muscle myosin light chain poly- 
Figure 6.  Two-dimensional  peptide maps of ~25I-labeled myosin heavy chains reveal numerous distinct  differences  between  cytoplasmic 
and muscle isoforms of  Drosophila myosin heavy chain. Autoradiographs of  two-dimensional  peptide maps are oriented with electrophoretic 
and chromatographic dimensions horizontally (anode toward the right) and vertically,  respectively.  The end panels are labeled  to indicate 
maps of cytoplasmic (Cyto) and muscle (Musc) isoforms.  The center panel  (Comb) was spotted  with equal  amounts of cytoplasmic and 
muscle myosin peptides and serves to compare peptides despite small anomalies in the migration of identical peptides  on individual plates. 
Several  of the peptides  unique to the cytoplasmic and muscle isoforms are indicated  with  solid  and open arrows,  respectively. 
Kiehart and Feghali Cytoplasmic  Myosin  1523 Figure 7. Cytoplasmic and muscle myosin heavy chain isoforms can be distinguished immunologically. Antibody overlay of Western blots 
demonstrates that polyclonal antisera raised against Drosophila cytoplasmic and muscle myosin isoforms react selectively with the heavy 
chain of the isoform against which they were made. Shown are  14 nitrocellulose blots, each containing a dilution series (1, 10,  100, or 
1,000 ng, labeled 1, 10, 102, 103 in one of the panels) of hydroxylapatite-purified  Drosophila cytoplasmic (c) or muscle (m) myosin. Two 
blots at the left were stained with Amido black. The lanes containing 1,000 ng of protein are readily visible, the lanes with 100 ng are 
less so. 1 and 10 ng of protein are not detected by the Amido black. The 12 remaining blots (six cytoplasmic, c, and six muscle, m) were 
stained with three different dilutions (200-, 632-, or 2,000-fold dilutions in STTMB) of anti-Drosophila cytoplasmic (top, anti-cyto) or 
anti-Drosophila muscle myosin (bottom, anti-musc) as shown. Peroxidase-labeled second antibody (diluted 1,000-fold)  was used to localize 
antibody binding to the blots. 
peptides,  two independent peptide mapping protocols and 
six independent polyclonal antisera establish that the cyto- 
plasmic isoform of Drosophila myosin heavy chain is struc- 
turally and immunologically distinct from the isoform iso- 
lated from thoraces of adult flies. 
The two-dimensional peptide maps reveal some homology 
between cytoplasmic and muscle isoforms, but clearly dem- 
onstrate significant differences in the constituent peptides of 
the myosin heavy chains. One-dimensional peptide maps es- 
tablish that the differences  between the polypeptides revealed 
by the two-dimensional mapping protocol were not simply 
an  artifact of differential iodination of tyrosine,  cysteine, 
histidine, or tryptophan residues on the respective peptides. 
Six polyclonal antisera, one rabbit, and two mouse sera 
directed against the cytoplasmic isoform, and one rabbit and 
two mouse sera directed against the muscle isoform, under- 
score the differences between these molecules. These find- 
ings suggest that the two Drosophila isoforms are as different 
as cytoplasmic and striated muscle isoforms of myosin iso- 
lated from vertebrate sources. 
It is clear that differential splicing of myosin heavy and 
light chain genes gives rise to heterogeneity in the mature 
messenger RNAs that encode for various isoforms of Dro- 
sophila muscle myosin heavy and light chains (Bernstein et 
al., 1983; Rozek and Davidson, 1983; 1986; Bernstein et al., 
1986; Falkenthal et al., 1985). However, differential splicing 
results in significant changes in the sequence of the 3' un- 
translated  region  of both  myosin  heavy  and  light  chain 
mRNAs  and  can  account  for only minor  changes  in  the 
amino acid sequence near the carboxy-termini of these poly- 
peptides.  One muscle myosin heavy chain isoform has 27 
unique carboxy-terminal amino acids,  while the other iso- 
form  has  a  single,  unique  carboxy-terminal  amino  acid 
(Bernstein et al.,  1986; Rozek and Davidson,  1986). Differ- 
ential splicing of the Drosophila alkali light chain primary 
transcript results in two isoforms that differ only in the se- 
quence of the 14 amino acids at their carboxy-terminal ends 
(Fallkenthal et al., 1985). Thus, no currently known differen- 
tial splicing patterns could account for the extensive differ- 
ences in the myosin polypeptide isoforms that we document 
through structural and immunological analyses of the puri- 
fied proteins. 
In concert, the observations provide good, albeit circum- 
stantial evidence for the existence of at least one additional 
myosin heavy chain gene in Drosophila. Since our data sug- 
gest that the cytoplasmic and muscle isoforms are substan- 
tially different at the polypeptide level, it is not surprising 
that the existence of a second myosin heavy chain gene was 
missed  when  muscle  myosin  DNA  probes  were  used  to 
search for additional myosin genes in Drosophila (Bernstein 
et al.,  1983;  Rozek and Davidson,  1983).  Supporting this 
conclusion is  the observation that,  although hybridization 
between nematode muscle and Acanthamoeba myosin genes 
shows some detectable homology between muscle and cyto- 
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myosin DNA probes have failed to identify  unambiguously 
the gene(s) for cytoplasmic myosin (Leinwand,  L., personal 
communication).  Unequivocal  demonstration  of the  exis- 
tence of a second myosin heavy chain gene in Drosophila  that 
encodes the cytoplasmic myosin isoform will require iden- 
tification  and cloning of the cytoplasmic  gene and  subse- 
quently its detailed comparison with the gene for the muscle 
isoform that has already been identified  and cloned. 
The study of the myosin polypeptides and their genes in 
Drosophila may be particularly  rewarding because, in con- 
trast to the vertebrate systems,  the apparently small number 
of myosin genes (perhaps as few as two) should allow a more 
complete description  of the relationships  between myosin 
genes, the regulation of their expression, and the functional 
importance  of the  diversity  between  the polypeptide  iso- 
forms that they encode. In addition,  classical genetics and 
modern molecular biology,  including  mutant analysis,  re- 
verse genetics, production of anti-sense message, and germ 
and somatic cell line transformation can be brought to bear 
on the mechanism of myosin function and the role this pro- 
tein  plays  in  cellular  homeostasis and  movements during 
early  embryogenesis. 
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